Sudden cardiac death and stroke with the use of antipsychotic medications: Implications for clinicians treating individuals with traumatic brain injury

Journal of Head Trauma Rehabilitation

Volumn 25, Issue 1, 2010, Pages 68-70

  Glenn, Mel B ^a  

^a and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PHENOTHIAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE;

ADULT; AGED; AGRANULOCYTOSIS; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DISEASE ASSOCIATION; DRUG USE; ELECTROCARDIOGRAM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GENERAL PRACTICE; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; POISSON DISTRIBUTION; PSYCHOPHARMACOTHERAPY; QT PROLONGATION; REGRESSION ANALYSIS; RISK ASSESSMENT; SCHIZOPHRENIA; SHORT SURVEY; SIDE EFFECT; STROKE; SUDDEN DEATH; TARDIVE DYSKINESIA; TORSADE DES POINTES; TRAUMATIC BRAIN INJURY; WEIGHT GAIN;

AGGRESSION; ANTIPSYCHOTIC AGENTS; BRAIN INJURIES; CRISIS INTERVENTION; DEATH, SUDDEN, CARDIAC; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LONG QT SYNDROME; STROKE; TREATMENT OUTCOME;

EID: 75649110494     PISSN: 08859701     EISSN: None     Source Type: Journal    
DOI: 10.1097/HTR.0b013e3181be1eab     Document Type: Short Survey

References (15)

1. Glenn MB, Wroblewski B. Twenty years of pharmacology. J Head Trauma Rehabil. 2005;20(1):51-61.
2. Hoffman AN,Cheng JP, Zafonte RD, Kline AE. Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits. Life Sci. 2008;83(17/18):602-607.
3. Elovic EP, Jasey NN Jr, Eisenberg ME. The use of atypical antipsychotics after traumatic brain injury. J Head Trauma Rehabil. 2008;23(2):132-135.
4. RayWA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry. 2001;58(12):1161- 1167.
5. Straus SM, Bleumink GS, Dieleman JP, et al. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med. 2004;164(12):1293-1297.
6. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiatry. 2002;180:515-522.
7. Hennessy S, Bilker WB, Knauss JS, et al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ. 2002;325(7372): 1070.
8. Health Canada. Important drug safety information: Risperdal (risperidone) and cerebrovascular adverse events in placebocontrolled dementia trials. Toronto: Janssen-Ortho Inc. http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories- avis/prof/ 2002/risperidal hpc-cps-eng.php. Accessed December 4, 2009.
9. Gill SS, Rochon PA, Herrmann N, et al. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ. 2005;330(7489):445.
10. Herrmann N, Mamdani M, Lanctot KL. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry. 2004;161(6):1113-1115.
11. Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry. 2007;64(2):242-249.
12. Osborn DP, Nazareth I, KingMB. Risk for coronary heart disease in people with severe mental illness: cross-sectional comparative study in primary care. Br J Psychiatry. 2006;188:271-277. (Pubitemid 43341656)
13. Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl JMed. 2009;360(3):225-235.
14. Douglas IJ, Smeeth L. Exposure to antipsychotics and risk of stroke: self controlled case series study. BMJ. 2008;337:a1227.
15. Schneeweiss S, Avorn J. Antipsychotic agents and sudden cardiac death-how should we manage the risk? N Engl J Med. 2009;360(3):294-296.